What SpaceX IPO really means for Virgin Galactic stock

What SpaceX IPO really means for Virgin Galactic stock
Wajeeh Khan
29 May 2026, 22:00 PM

powered by

Invezz
SPCE momentum long

Buy Virgin Galactic (SPCE). The article shows a clear “IPO halo” bid already lifting SPCE as investors park money in liquid proxies (Rocket Lab, Intuitive Machines, SPCE) ahead of SpaceX’s listing. Add the near-term positive: settlement of two derivative lawsuits and the upcoming Delta-class flight-testing window (Q3) with rocket-powered flights targeted for Q4. Thesis: the market keeps paying for optionality until SpaceX actually lists and capital rotates.

Key Risk: SpaceX listing triggers fast capital rotation out of proxy names, and SPCE’s Delta milestones slip or fail to re-rate the stock.

Rocket Lab relative value short

Sell Rocket Lab (RKLB) versus SPCE. Both are proxy beneficiaries, but RKLB has less direct “event re-rating” tied to the specific Delta-class catalyst discussed for SPCE. When SpaceX goes live, the halo should fade first for the most crowded, high-beta proxy trades; SPCE’s next catalyst (Delta flight testing) can keep it supported longer. Thesis: RKLB underperforms SPCE after the rotation.

Key Risk: RKLB’s own launch/contract news accelerates re-rating right as the SpaceX halo fades, keeping RKLB bid.

  • Virgin Galactic stock is ripping higher ahead of SpaceX IPO.
  • But things could take a dramatic turn once SpaceX goes live.
  • SPCE shares are currently up more than 150% versus its YTD low.

SpaceX has filed its IPO prospectus, targeting a Nasdaq listing under the ticker symbol SPCX with a valuation floor of $1.8 trillion and a capital raise of $75 billion, which would make it the “largest” public offering in history.

And while it’s a seismic moment for the space industry, for those holding Virgin Galactic SPCE shares, what’s more important is analyzing what happens to the smaller, scrappier player once the giant enters the room.

SpaceX IPO is lifting Virgin Galactic stock – for now

Here’s a dynamic that Wall Street rarely spells out plainly: when a sector titan goes public, smaller players in that space all see their stock prices rise in anticipation.

That is exactly what’s been happening to SPCE shares in recent sessions.

Since SpaceX is not yet listed, investors have been buying liquid proxy names, including Intuitive Machines, Rocket Lab, and Virgin Galactic.

At the time of writing, SPCE is up more than 150% versus its year-to-date low, on the back of the SpaceX IPO halo effect and settlement of two longstanding shareholder derivative lawsuits.

Simply put, the momentum is genuine – but it may be on borrowed time.

What happens to SPCE shares once SpaceX goes live

Interestingly, the very catalyst that’s boosted Virgin Galactic stock in recent sessions could become its biggest headwind by late June.

Once SpaceX lists, capital will likely rotate out of proxy names like SPCE and directly into SpaceX – meaning the IPO halo would eventually become a bearish catalyst.

The fundamentals make this rotation risk even sharper.

Starlink, the giant’s satellite internet unit, now serves 10.3 million users across 164 countries, generates $3.26 billion per quarter in revenue, and throws off $1.19 billion in operating profit every three months.

That is the kind of scale and profitability that Virgin Galactic simply can’t match.

SPCE posted a $65 million net loss for Q1 and is still gearing up for flight testing of its new Delta-class spaceship in the third quarter, with roughly 650 ticket reservations on the books.

When investors can choose between a $1.8 trillion revenue-generating rocket company and a pre-sales space tourism startup still assembling its first next-gen vehicle, the calculus isn’t particularly close.

How to play Virgin Galactic heading into SpaceX IPO

Virgin Galactic is a pre-revenue, high-burn aerospace firm that carried a going concern disclosure in its 2025 annual report.

That is not a red flag to be brushed past – it is the company itself telling you the risks are existential. Still, there’s a real catalyst on the horizon.

As mentioned earlier, SPCE is set to begin flight testing its first Delta-class spaceship in Q3, with rocket-powered spaceflight targeted for the final quarter.

Tickets are also back on sale at $750,000 per seat.

If the Delta program hits its milestones and the NYSE-listed firm begins generating actual revenue, the thesis changes considerably.

That said, with SpaceX about to absorb enormous institutional capital, SPCE stock faces a “fierce battle” for investor attention.

This is a speculative play for high-risk tolerant investors only – not a conviction buy for the cautious.